Mebanazin

Mebanazin
(IUPAC) ime
	1-feniletilhidrazin
Klinički podaci
Identifikatori
CAS broj	65-64-5
ATC kod	nije dodeljen
PubChem	6179
ChemSpider	5944
UNII	Z5R55CJ4CG
ChEMBL	CHEMBL1909283
Hemijski podaci
Formula	C8H12N2
Mol. masa	136,19 g/mol
SMILES	eMolekuli&PubHem
InChI
	InChI=1S/C8H12N2/c1-7(10-9)8-5-3-2-4-6-8/h2-7,10H,9H2,1H3; Key: HHRZAEJMHSGZNP-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status	℞Prescription only
Način primene	Oralno

Mebanazin(Actomol) jeinhibitor monoaminske oksidaze(MAOI) izhidrazinske hemijske klase,koji je ranije korišten kaoantidepresivtokom 1960-tih, ali je njegova primena prekinuta.^[5]^[6]^[7]

Reference

↑Li Q, Cheng T, Wang Y, Bryant SH (2010).„PubChem as a public resource for drug discovery.”.Drug Discov Today15(23-24): 1052-7.DOI:10.1016/j.drudis.2010.10.003.PMID 20970519.edit
↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”.Annual Reports in Computational Chemistry4:217-241.DOI:10.1016/S1574-1400(08)00012-1.
↑Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010).„Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”.J Cheminform2(1): 3.DOI:10.1186/1758-2946-2-3.PMID 20331846.edit
↑Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”.Nucleic Acids Res40(Database issue): D1100-7.DOI:10.1093/nar/gkr777.PMID 21948594.edit
↑Gilmour SJ (September 1965). „Clinical trial of mebanazine--a new monoamine oxidase inhibitor”.The British Journal of Psychiatry: the Journal of Mental Science111(478): 899–902.PMID 5889715.
↑Barker JC, Jan IA, Enoch MD (November 1965). „A controlled trial of mebanazine ('Actomol') in depression”.The British Journal of Psychiatry: the Journal of Mental Science111(480): 1095–100.PMID 5320546.
↑Knott F (1965).„A preliminary trial of mebanazine in depressive states”.The Journal of New Drugs5(6): 345–7.PMID 5327282.Arhivirano izoriginalana datum 2019-12-15.Pristupljeno 2014-04-05.

Povezano

Hidrazin (antidepresiv)

Spoljašnje veze

	Portal Medicina
	Portal Hemija

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010).„PubChem as a public resource for drug discovery.”.Drug Discov Today15(23-24): 1052-7.DOI:10.1016/j.drudis.2010.10.003.PMID 20970519.edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”.Annual Reports in Computational Chemistry4:217-241.DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010).„Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”.J Cheminform2(1): 3.DOI:10.1186/1758-2946-2-3.PMID 20331846.edit

[4] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”.Nucleic Acids Res40(Database issue): D1100-7.DOI:10.1093/nar/gkr777.PMID 21948594.edit

[pmid5889715-5] Gilmour SJ (September 1965). „Clinical trial of mebanazine--a new monoamine oxidase inhibitor”.The British Journal of Psychiatry: the Journal of Mental Science111(478): 899–902.PMID 5889715.

[pmid5320546-6] Barker JC, Jan IA, Enoch MD (November 1965). „A controlled trial of mebanazine ('Actomol') in depression”.The British Journal of Psychiatry: the Journal of Mental Science111(480): 1095–100.PMID 5320546.

[pmid5327282-7] Knott F (1965).„A preliminary trial of mebanazine in depressive states”.The Journal of New Drugs5(6): 345–7.PMID 5327282.Arhivirano izoriginalana datum 2019-12-15.Pristupljeno 2014-04-05.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

Mebanazin

Reference

Povezano

Spoljašnje veze

Navigacija

Pretraga